Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The company presented data showing that a single IV dose of its ctLNP delivered mRNA encoding a reporter protein to a ...

Zylem Biosciences, a company specializing in cancer and cardiovascular therapeutics, announced that Northwestern University has filed a lawsuit against Moderna, alleging infringement of key patents ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.